Skip to main content

Table 2 List of Mycobacterium tuberculosis isolates tested against ertapenem and faropenem

From: Ertapenem and Faropenem against Mycobacterium tuberculosis: in vitro testing and comparison by macro and microdilution

Strain Phenotypical resistance profile Meropenem
clavulanate
MIC (μg/ml)
Notes
03:013 S 32 MonoR
03:039 H 16 MonoR
04:018 H, R, clari, ethi Failed MDR
05:094 Fully susceptible 8  
07:116 H, ethi 4 PolyR
11:136 S,H,R > 32 MDR
11:156 S,H,R 4 MDR
11:191 H 16 MonoR
11:368 S,H,R > 32 MDR
324 Fully susceptible 8  
333 S,H,R 2 MDR
346 S,H,R 2 MDR
347 Fully susceptible > 32  
401 H,R > 32 MDR
408 S, H, R > 32 MDR
443 Fully susceptible > 32  
548 N/A* > 32 XDR
421 S, H, R, EMB, CAP, Moxi > 32 XDR
433 S, H, R, EMB, PYR, CAP, Moxi 8 XDR
H37Rv Fully susceptible 2 Control reference strain
  1. MDR Multi-Drug resistant; XDR Extensively drug resistance; MonoR Resistant to one drug only; PolyR Resistant to more than one drug other than H/R. The resistance profile is shown in the second column, with a variety of fully susceptible, MonoR, MDR and XDR samples (S Streptomycin, H Isoniazid, R Rifampicin, Clari Clarithromycin, Ethi Ethionamide, EMB Ethambutol, CAP=Capreomycin, Moxi = Moxifloxacin, PYR = Pyrazinamide). The MIC against Meropenem/clavulanate is also shown